Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 147.95B | 149.90B | 137.59B | 137.48B | 121.84B | 187.70B |
Gross Profit | 14.94B | 14.66B | 13.37B | 13.16B | 12.51B | 11.70B |
EBITDA | 4.62B | 6.78B | 5.30B | 4.26B | 4.16B | 3.75B |
Net Income | 2.97B | 2.90B | 2.13B | 1.39B | 1.15B | 1.26B |
Balance Sheet | ||||||
Total Assets | 86.94B | 74.76B | 78.42B | 73.29B | 71.61B | 68.86B |
Cash, Cash Equivalents and Short-Term Investments | 6.31B | 5.53B | 7.11B | 8.36B | 7.54B | 9.59B |
Total Debt | 22.73B | 19.24B | 24.46B | 28.03B | 24.74B | 24.61B |
Total Liabilities | 53.37B | 40.95B | 47.42B | 47.17B | 42.58B | 41.61B |
Stockholders Equity | 31.83B | 32.04B | 29.32B | 24.47B | 24.43B | 23.14B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 3.41B | 2.18B | 2.36B | -2.67B | 3.99B |
Operating Cash Flow | 0.00 | 3.92B | 3.59B | 3.34B | -814.00M | 5.42B |
Investing Cash Flow | 0.00 | 397.00M | -637.00M | -666.00M | -795.00M | -1.83B |
Financing Cash Flow | 0.00 | -5.89B | -4.21B | -1.86B | -453.00M | -1.65B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥19.09B | 6.22 | 4.26% | 7.08% | -1.44% | ||
76 Outperform | ¥13.84B | 4.77 | 3.18% | 8.95% | 35.94% | ||
75 Outperform | ¥16.97B | 12.04 | 2.42% | 3.22% | 7.14% | ||
69 Neutral | ¥4.53B | 3.87 | 1.76% | 0.86% | 17.20% | ||
68 Neutral | S$3.36B | 16.76 | -11.82% | 6.07% | 5.14% | -8.01% | |
58 Neutral | ¥2.72B | 87.01 | 0.94% | 0.80% | -25.72% | ||
57 Neutral | ¥7.91B | 27.40 | 0.99% | 6.33% | 40.40% |